Interaction between PD-1 and the TME, as well as ensuring cancer immunotherapy therapeutics. The paper mentions the inhibition of PD-1, PD-L1, and PD-L2, the construction of CAR-T, and tumor vaccines as popular therapeutic approaches. This evidence concerns the gene PDCD1LG2 and cancer.